Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The global electrocardiography market accounted for $XX million in 2016 and is expected to reach $XX million by 2022 at a CAGR of XX%. Increasing incidence of lifestyle-related disease and cardiovascular diseases, increased life expectation and the rising geriatric population, technological advancements are some of the key drivers of the electrocardiography market. There is also an increasing demand for portable monitoring and diagnostic devices. The high demand for electrocardiography services has led of increasing investment in research and development of electrocardiograph devices.
The medical device industry is one of the biggest industries in the healthcare sector. With the increasing penetration of health care in many developing geographies and increasing demand for medical services as a result of development will lead to greater demand for medical devices like electrocardiograph.
Market Segmentation
The electrocardiograph market can be segmented product wise - diagnostic ECG systems, stress ECG systems, monitoring ECG systems, cardiovascular monitoring. Based on technology the market can be segmented into conventional ECG systems, wireless ECG systems, and portable ECG systems. On lead types, the market can be segmented into 12 Lead ECG systems, 3-6 Lead ECG systems, single lead EG systems. The market can also be segments based on end user - hospitals, diagnostic centers, research centers, home user.
Regional/Geographic Analysis
The US is the dominant market for ECG devices. The market for ECG devices in the Asia Pacific region is expected to grow to the increasing population suffering from cardiovascular disease especially in countries like India.
Key Players
GE Healthcare, Koninklijke Philips N.V., Welch Allyn, Nihon Kohden Corporation, Mortara Instrument, Inc.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...